Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
464 Markers on platelet microvesicles for diagnostics of ovarian cancer
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health. (Inger Sundström Poromaa)
Show others and affiliations
2021 (English)In: International Journal of Gynecologic Cancer, Vol. 31, no Suppl 3Article in journal, Meeting abstract (Refereed) Published
Abstract [en]

Introduction/Background*Routine blood markers provide poor diagnostic capacity for ovarian cancer. Ultrasound examination using the criteria developed by International Ovarian Tumor Analysis group is the most sensitive and specific diagnostic method, but in up to 20% of cases evaluation is inconclusive (Sladkevicius et al. 2020; Valentin et al. 2011). We pioneered platelet proteome analysis and identified platelet biomarkers of ovarian cancer (Lomnytska et al. 2018).Methodology The purpose of the study is to identify diagnostic marker panel on platelet microvesicles in blood plasma for non-invasive differential diagnostics of benign adnexal lesions, borderline tumours and ovarian cancer. The expression of platelet protein biomarkers on platelet microvesicles in patients with benign and malignant adnexal lesions was analysed using flow cytometry. Identified biomarker panels were analysed together with the gynaecologic ultrasound criteria.Result(s)*Analysis comprised 39 patients with benign adnexal lesions (n=10), borderline (n=10), ovarian cancer stage I-II (n=8) and stage III-IV (n=11). Using flow cytometry analysis of platelet microvesicles in platelet-poor blood plasma, we detected our previously identified by proteome analysis of platelets markers ACTN4, CRKL, ERP29, GELS, PHB and SRC (Lomnytska et al., 2018). Expression of P-selectin positive platelet microvesicles was 2-fold higher in ovarian cancer (p<0.05). Increased expression of our identified markers on P-selectin positive platelet microvesicles was observed in ovarian cancer (figure 1).Abstract 464 Figure 1 Conclusion*Identified platelet biomarkers (Lomnytska et al. 2018) are detectable on platelet microvesicles in blood plasma with increased expression in ovarian cancer. Further analysis of microvesicles in relation to ultrasound evaluation has the potential to improve ovarian cancer diagnostics.

Place, publisher, year, edition, pages
2021. Vol. 31, no Suppl 3
National Category
Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
URN: urn:nbn:se:uu:diva-459610DOI: 10.1136/ijgc-2021-ESGO.406OAI: oai:DiVA.org:uu-459610DiVA, id: diva2:1614552
Available from: 2021-11-25 Created: 2021-11-25 Last updated: 2025-02-11

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full texthttp://ijgc.bmj.com/content/31/Suppl_3/A237.2.abstract

Authority records

Lomnytska, Marta

Search in DiVA

By author/editor
Lomnytska, Marta
By organisation
Department of Women's and Children's HealthReproductive Health
Gynaecology, Obstetrics and Reproductive Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 150 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf